Decorated of silver nanoparticles over Arabic gum modified magnetic nanoparticles: Evaluation of its antioxidant and its therapeutic effects on cervical cancer
Source abstract
Abstract
In the current work, we report the bio-inspired formulation of silver NPs fabricated over Arabic gum (AG) functionalized magnetic nanocomposite (Fe 3 O 4 @AG/Ag NPs) for the treatment of cervical cancer. In the stepwise modification approach, the pre-synthesized Fe 3 O 4 NPs were encapsulated by the Arabic gum polar organomolecules, followed by the decoration of in-situ green synthesized silver NPs over the composite. The final bio-material was characterized by various analytical techniques such as XRD, EDX, ICP-OES, TEM, FE-SEM, and FT-IR. The FE-SEM findings validate the spherical shape of the Fe 3 O 4 @AG/Ag NPs, which range in size from 20 to 35 nm. An assessment was conducted on the characteristics of Fe 3 O 4 @AG/Ag NPs in relation to prevalent human cervical cancer cells. The DPPH free radical antioxidant assay demonstrates the notable antioxidant characteristics of Fe3O4@AG/Ag NPs. The Fe 3 O 4 @AG/Ag NPs exhibited IC 50 values of 115, 90, 119, and 80 when tested against SiHa, C-33 A, Ca Ski, and LM-MEL-41 cells, respectively. The anti-human cervical cancer effect of Fe 3 O 4 @AG/Ag NPs appears to be a result of their antioxidant properties. According to the findings mentioned above, there is a potential for the newly created Fe 3 O 4 @AG/Ag NPs to be utilized as an innovative chemotherapeutic treatment or supplement for managing cervical cancer after the conclusion of clinical trials with human participants.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Curcumin's Biomedical Applications · Pharmacology and Nanomedicine Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Li · BMC Cancer · 2022 · 22 · 87610.1186/s12885-022-09970-x ↗
2. Wen · CytoJournal · 2023 · 20 · 2610.25259/Cytojournal_46_2022 ↗
3. Tan · Cancer Nanotechnology · 2023 · 14 · 7010.1186/s12645-023-00194-7 ↗
4. Lee · J. Gynecologic Oncol · 2016 · 27
5. Rob · Int. J. Hyperther. · 2012 · 28 · 48910.3109/02656736.2012.675116 ↗
6. Zhang · J. Cancer · 2018 · 9 · 177310.7150/jca.24577 ↗
7. Maney · Pharmaceutics · 2019 · 11
8. Song · Front. Oncol. · 2024 · 14
9. Cancio · Surg. Infect. · 2021 · 22 · 310.1089/sur.2020.368 ↗
10. Rowan · Crit. Care · 2015 · 19 · 1210.1186/s13054-015-0961-2 ↗
11. Zangeneh · Appl. Organomet. Chem. · 2020 · 34
12. Hemmati · Appl. Organomet. Chem. · 2020 · 34
13. Zhaleh · Appl. Organomet. Chem. · 2019 · 3310.1002/aoc.5015 ↗
14. Shahriari · Appl. Organomet. Chem. · 2019 · 33 · e518910.1002/aoc.5189 ↗
15. Shahriari · Appl. Organomet. Chem. · 2020 · 3410.1002/aoc.5476 ↗
16. Zangeneh · Appl. Organomet. Chem. · 2019 · 33
17. Zangeneh · Appl. Organomet. Chem. · 2019 · 33
18. Ahmeda · Appl. Organomet. Chem. · 2020 · 34
19. Zangeneh · Appl. Organomet. Chem. · 2020 · 34
20. Li · Stem Cell Res. Ther. · 2020 · 11 · 32210.1186/s13287-020-01839-9 ↗
21. Zhang · Biomaterials · 2020 · 230
22. Li · Adv. Mater. · 2024 · 36
23. Yu · Nat. Commun. · 2022 · 13 · 424110.1038/s41467-022-31997-8 ↗
24. Chang · Radiol. Oncol. · 2019 · 53 · 44310.2478/raon-2019-0048 ↗
25. Yan · Adv. Sci. · 2019 · 6
26. Singh · Signal Transduct Tar · 2019 · 4 · 3310.1038/s41392-019-0068-3 ↗
27. Wang · Curr. Pharmaceut. Biotechnol. · 2023 · 24 · 163010.2174/1389201024666230313151316 ↗
28. Anwanwan · Biochim. Biophys. Acta Rev. Canc · 2020 · 1873
29. Yi · Nano Res. · 2022 · 15 · 120510.1007/s12274-021-3626-2 ↗
30. Zhu · Adv. Mater. · 2019 · 31
31. Li · Small · 2022 · 18
32. Li · Opt Laser. Technol. · 2022 · 148
33. Luo · Colloids Surf. B Biointerfaces · 2021 · 201
34. Lv · Ecotoxicol. Environ. Saf. · 2024 · 272
35. Bakrania · Pharmaceutics · 2021 · 14
36. Yang · Front. Bioeng. Biotechnol. · 2022 · 10
37. Wang · Cancer Med. · 2024 · 13
38. Dai · Drug Discov. Today · 2024 · 2910.1016/j.drudis.2024.103981 ↗
39. Liu · J. Am. Chem. Soc. · 2022 · 144 · 1890810.1021/jacs.2c06538 ↗
40. He · Chem. Commun. · 2021 · 57 · 1241710.1039/D1CC04846E ↗
41. Zhao · ACS Nano · 2024 · 18 · 1785210.1021/acsnano.4c04022 ↗
42. Sykes · Expet Rev. Gastroenterol. Hepatol. · 2012 · 6 · 34310.1586/egh.12.13 ↗
43. Zangeneh · Appl. Organomet. Chem. · 2019 · 33
44. Zangeneh · Appl. Organomet. Chem. · 2019 · 33
45. Zangeneh · Appl. Organomet. Chem. · 2020 · 34
46. Zangeneh · Appl. Organomet. Chem. · 2019 · 33 · e524610.1002/aoc.5246 ↗
47. Mahdavi · Appl. Organomet. Chem. · 2019 · 33 · e524810.1002/aoc.5164 ↗
48. Zangeneh · Comp. Clin. Pathol. · 2019 · 28 · 148310.1007/s00580-019-02997-w ↗
49. Soleymani · Inorg. Chem. Commun. · 2024 · 16010.1016/j.inoche.2023.111998 ↗
50. He · Inorg. Chem. Commun. · 2024 · 16010.1016/j.inoche.2024.112021 ↗
51. Soltani · Inorg. Chem. Commun. · 2024 · 15910.1016/j.inoche.2023.111847 ↗
52. Gu · J. Exp. Nanosci. · 2022 · 17 · 28510.1080/17458080.2022.2066082 ↗
53. Wei · Anal. Bioanal. Chem. · 2022 · 402 · 105710.1007/s00216-011-5591-1 ↗
54. Locatelli · Nanomedicine · 2014 · 9 · 83910.2217/nnm.14.1 ↗
55. Gengan · Colloids Surf. B Biointerfaces · 2013 · 105 · 8710.1016/j.colsurfb.2012.12.044 ↗
56. Jeyaraj · Colloids Surf. B Biointerfaces · 2013 · 102 · 70810.1016/j.colsurfb.2012.09.042 ↗
57. Sanpui · ACS Appl. Mater. Interfaces · 2011 · 3 · 21810.1021/am100840c ↗
58. Jeyaraj · Colloids Surf. B Biointerfaces · 2013 · 106 · 8610.1016/j.colsurfb.2013.01.027 ↗
59. Sriram · Int. J. Nanomed. · 2010 · 5 · 753
60. Hsin · Toxicol. Lett. · 2008 · 179 · 13010.1016/j.toxlet.2008.04.015 ↗
61. Gurunathan · Biomaterials · 2009 · 30 · 634110.1016/j.biomaterials.2009.08.008 ↗
62. De Lima · J. Appl. Toxicol. · 2012 · 32 · 86710.1002/jat.2780 ↗